Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2022

$3,495.00

The Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2022 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies

Publication date
April 2022
Number of pages
2,500+
Product type
Research report
Available formats
PDF document
Report edition
3
SKU
CP2063

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 - 2022 report provides comprehensive understanding and unprecedented access to the licensing deals and agreements entered into by the worlds leading life science companies.

 

This report provides details of the latest licensing agreements announced in the pharmaceutical, biotechnology and diagnostic sectors. Fully up to date, the report provides details of licensing agreements from 2016 to 2022.

 

There has been a long standing willingness for parties to enter licensing deals. Such deals enable both parties to benefit from the upside of a big R&D win, whilst mitigating the risks of going it alone in the risky preclinical and clinical development stages.

 

Licensing is a specific type of partnering deal whereby the parties to the deal agree to commercialize a compound, product or technology.

 

Specifically, licensing is the granting of permission to use intellectual property rights, such as trademarks, patents, or technology, under defined conditions

 

There are several forms of licensing deal. Traditional licensing arrangement whereby an owner of intellectual property (the licensor) provides access to its technology to another company (the licensee) in return for agreed payments and royalties on subsequent sales of product(s) derived from the intellectual property.

 

In more recent times, licensing is often the outcome of a successful period of collaboration on the research and development of a technology or compound, resulting in a product which can be commercialized. In this situation, the licensing agreement governs who has permission to commercialize and what payments are due should commercialization proceed.

 

Other forms of licensing such as sub-licensing and cross-licensing are also explored, with examples provided together with listing of recent deals in pharma, biotech and diagnostics.

 

The report provides a detailed understand and analysis of how and why companies enter licensing deals. The majority of deals are multicomponent whereby the licensee retains either a right or option to license to commercialize the resultant product of the research collaboration. There are also numerous pure licensing deals whereby the products originator takes on a development/commercialization partner in order to maximize a technologies/products prospects.

 

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payment clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

 

This report contains a comprehensive listing of all licensing deals announced since 2016 as recorded in the Current Agreements deals and alliances database, including financial terms where available, plus links to online copies of actual licensing contract documents as submitted to the Securities Exchange Commission by companies and their partners.

 

Contract documents provide the answers to numerous questions about a prospective partner’s flexibility on a wide range of important issues, many of which will have a significant impact on each party’s ability to derive value from the deal.

 

The initial chapters of this report provide an orientation of licensing deal making and business activities. Chapter 1 provides an introduction to the report, whilst chapter 2 provides an analysis of the trends in licensing as well as a discussion on the merits of the type of deal.

 

Chapter 3 provides an overview of the structure of licensing deals. The chapter includes numerous case studies to enable understanding of both pure licensing deals and multicomponent deals where collaborative R&D forms a part.

 

Chapter 4 provides a review of the leading licensing deals since 2016. Deals are listed by headline value. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

 

Chapter 5 provides a review of the top 25 most active biopharma companies in licensing. Where the deal has an agreement contract published at the SEC a link provides online access to the contract via the Current Agreements deals and alliances database.

 

Chapter 6 provides a comprehensive review of licensing financials for deals announced since 2016, including headline value, upfront, milestone payments and royalty rates, providing both benchmark data and access to individual deal financials.

 

Chapter 7 provides a comprehensive and detailed review of licensing deals signed and announced since 2016 where a contract document is available. Each deal title links via Weblink to an online version of the actual contract document, providing easy access to each contract document on demand.

 

The report includes deals announced by hundreds of life science companies including big pharma such as Abbott, Abbvie, Actavis, Amgen, Astellas, AstraZeneca, Baxter, Bayer, Biogen Idec, BMS, Celgene, Eisai, Eli Lilly, Gilead, GSK, J&J, Kyowa Hakko, Merck, Mitsubishi, Mylan, Novartis, Pfizer, Roche, Sanofi, Shire, Takeda, Teva, and Valeant, amongst many others.

 

The report also includes numerous table and figures that illustrate the trends and activities in licensing deal making since 2016.

 

In addition, a comprehensive appendix is provided organized by licensing company A-Z , stage of development, therapeutic target, technology type and deal type definitions. Each deal title links via Weblink to an online version of the deal record and where available, the contract document, providing easy access to each contract document on demand.

 

In conclusion, this report provides everything a prospective dealmaker needs to know about licensing partnering in the research, development and commercialization of technologies and products.

 

Key benefits

 

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 - 2022 provides the reader with the following key benefits:

 

  • In-depth understanding of licensing partnering deal trends since 2016
  • Analysis of the structure of licensing agreements with real life case studies
  • Comprehensive listing of licensing deals since 2016, together with deal terms, value and press release
  • Comprehensive access to actual licensing contracts entered into by the world’s life science companies
  • Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
  • Insight into the terms included in a licensing agreement, together with real world clause examples
  • Understand the key deal terms companies have agreed in previous deals           
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

 

Report scope

 

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 - 2022 is intended to provide the reader with an in-depth understanding of the licensing trends and structure of deals entered into by leading life science companies worldwide.        

 

Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 - 2022 includes:

 

  • Trends in licensing dealmaking in the biopharma industry since 2016
  • Analysis of licensing deal structure
  • Case studies of real-life licensing deals
  • Comprehensive listing of licensing deals since 2016
  • Access to licensing contract documents
  • Key financial bnchmarks for headline, upfront, milestone and royalty rates
  • The leading licensing deals by value since 2016
  • Most active licensing dealmakers since 2016
  • The leading licensing partnering resources

 

In Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 - 2022 available deals and contracts are listed by:

 

  • Company A-Z
  • Headline value
  • Therapeutic area
  • Technology type

 

Each deal title links via Weblink to an online version of the actual deal record and where available, contract document, providing easy access to each contract document on demand.

 

The Global Licensing Partnering Terms and Agreements in Pharma, Biotech and Diagnostics 2016 - 2022 report provides comprehensive access to available contract documents for licensing deals. Analyzing actual contract agreements allows assessment of the following:

 

  • What are the precise rights granted or optioned?
  • What is actually granted by the agreement to the partner company?
  • What exclusivity is granted?
  • What is the payment structure for the deal?
  • How do milestone align with clinical stage development phases?
  • How are sales and payments audited?
  • What is the deal term?
  • How are the key terms of the agreement defined?
  • How are IPRs handled and owned?
  • Who is responsible for commercialization?
  • Who is responsible for development, supply, and manufacture?
  • How is confidentiality and publication managed?
  • How are disputes to be resolved?
  • Under what conditions can the deal be terminated?
  • What happens when there is a change of ownership?
  • What sublicensing and subcontracting provisions have been agreed?
  • Which boilerplate clauses does the company insist upon?
  • Which boilerplate clauses appear to differ from partner to partner or deal type to deal type?
  • Which jurisdiction does the company insist upon for agreement law?

Global Licensing Partnering Terms & Agreements in Pharma, Biotech & Diagnostics 2016-2022 provides the reader with the following key benefits:

 

  • In-depth understanding of licensing partnering deal trends since 2016
  • Insight into the terms included in a licensing agreement, together with real world clause examples
  • Identify leading licensing deals by value since 2016
  • Identify the most active licensing dealmakers since 2016
  • Analysis of key deal financials including headline value, upfront, milestone payments and royalty rates
  • Full listing of  licensing deals by company A-Z, deal value, phase of development, deal type, therapy and technology focus
  • Comprehensive access to licensing deals entered into by the world’s biopharma companies, together with contract documents if available
  • Detailed access to actual licensing contracts entered into by the leading big pharma and big biotech companies
  • Understand the key deal terms companies have agreed in previous deals
  • Undertake due diligence to assess suitability of your proposed deal terms for partner companies

Executive Summary

 

Chapter 1 – Introduction

 

Chapter 2 – Trends in licensing deal making

 

2.1. Introduction

2.2. Definition of licensing deals

2.3. Success factors for licensing deals

2.4. When licensing can be useful

2.5. Attributes of licensing deals

2.6. Trends in licensing deals since 2016

2.6.1. Licensing deal making by year since 2016

2.6.2. Licensing deal making by phase of development since 2016

2.6.3. Licensing deal making by industry sector since 2016

2.6.4. Licensing deal making by therapy area since 2016

2.6.5. Licensing deal making by technology type since 2016

2.6.6. Licensing deal making by most active company since 2016

2.7. Option to license

2.8. Adding co-promotion to the mix

2.9. The future of licensing deals

 

Chapter 3 – Overview of licensing deal structure

 

3.1. Introduction

3.2. Pure versus multi-component licensing deals

3.3. Pure licensing agreement structure

3.3.1. Example licensing agreements

3.3.1.a. Case study 1

3.3.1.b. Case study 2

3.4. Licensing rights as part of a wider alliance agreement

3.4.1. Example licensing clauses

3.4.1.a. Case study 3

3.4.1.b. Case study 4

3.4.2. Example licensing option right clauses

3.4.2.a. Case study 5

3.4.2.b. Case study 6

 

Chapter 4 – Leading licensing deals

 

4.1. Introduction

4.2. Top licensing deals by value

 

Chapter 5 – Top 25 most active licensing dealmakers

 

5.1. Introduction

5.2. Top 25 most active licensing dealmakers

 

Chapter 6 – Licensing deal term financials

 

6.1. Introduction

6.2. Licensing partnering headline values

6.3. Licensing deal upfront payments

6.4. Licensing deal milestone payments

6.5. Licensing royalty rates

 

Chapter 7 – Licensing contract directory since 2016

 

7.1. Introduction

7.2. Licensing deals with contracts since 2016

 

Appendices

 

Appendix 1 – Licensing dealmaking by companies A-Z

Appendix 2 – Licensing dealmaking by industry sector

Appendix 3 – Licensing dealmaking by stage of development

Appendix 4 – Licensing dealmaking by therapy area

Appendix 5 – Licensing dealmaking by technology type

 

About Wildwood Ventures

 

Current Partnering

Current Agreements

Recent report titles from Current Partnering

 

TABLE OF FIGURES

 

Figure 1: Definition of licensing

Figure 2: Situations where licensing can prove useful

Figure 3: Key attributes of a licensing deal

Figure 4: Trends in licensing deal announcements since 2016

Figure 5: Licensing deals signed at each phase of development since 2016

Figure 6: Licensing deals by industry sector since 2016

Figure 7: Licensing deals by therapy area since 2016

Figure 8: Licensing deals by technology type since 2016

Figure 9: Top 25 most active licensing dealmakers sinnce 2016

Figure 10: Licensing agreements – what should a contract include?

Figure 11: Components of the licensing deal structure

Figure 12: Top licensing deals by value since 2016

Figure 13: Most active licensing dealmakers since 2016

Figure 14: Licensing deals with a headline value

Figure 15: Licensing deals with an upfront value

Figure 16: Licensing deals with a milestone value

Figure 17: Licensing deals with a royalty rate value

Pricing options

  • $3,495: single-user
  • $5,245: multi-user
  • $10,495: single site license
  • $17,495: global site license

 

A full explanation of license type definitions can be found here.

 

Our guarantee

 

Price promise

We guarantee our prices are competitive. If you find the same report advertised at a lower price within 7 days of purchase, we will refund the difference.

 

Delivery Deadline

We guarantee that the report will be sent within the specified delivery times. In the unlikely case of a delay we may offer a partial refund as compensation. (Terms may apply)

 

Latest report

If an update is published within 30 days of your purchase, you will receive it absolutely free of charge.

 

Serious Security

We take your data and security seriously. See our privacy policy for details of how we manage your data.

All card payments are processed by SagePay.

 

Sales Support

If you have any questions about your report or are unhappy with the quality, we will do our best to resolve your query. Contact us direct.

 

Total Trust

Current Partnering is part of Wildwood Ventures Ltd., based in York, United Kingdom. We have been trading successfully online since 2009 and work with some of the most famous brands in the business. We carefully select our partners to ensure that the publications meet expectations of demanding customers.

2A, 2bPrecise, 2seventy bio, 2X Oncology, 3a-diagnostics, 3B Pharmaceuticals, 3D Medicines, 3E Bioventures Capital, 3M, 3P Biopharmaceuticals, 3rd People’s Hospital of Shenzhen, 3SBio, 3Shape, 4D Molecular Therapeutics, 4D Pharma, 4SC, 9 Meters Biopharma, 10X Genomics, 23andMe, 48Hour Discovery, 180 Life Sciences, 221b Foundation, A*STAR Agency for Science, Technology and Research, A1 Group, A2 Biotherapeutics, Aadi Bioscience, Aardvark Therapeutics, Aarhus University, Aarvik Therapeutics, AAVnerGene, AazeinTx, Abba Import Export, AB Biosciences, Abbisko Therapeutics, Abbott Laboratories, Abbott Vascular Devices, Abbvie, Abcam, AbCellera, AbClon, Abcuro, Ab E Discovery, Abeona Therapeutics, Abide Therapeutics, Ability Pharmaceuticals, Ab Initio, Abintus Bio, Ablaze Pharmaceuticals, ABL Bio, Ablexis, Ablynx, AbMed, Abmuno Therapeutics, Aboundbio, Abound Bio, Abpro, AbSci, Absorption Systems, Abuse Deterrent Pharmaceuticals, Abveris, ABX, Abzena, Acacia Pharma, Acacia Research, ACADIA Pharmaceuticals, Acasti Pharma, AC Bioscience, Accelerate Technologies, Accent Therapeutics, Accera Pharmaceuticals, Accord Healthcare, Accure Therapeutics, ACEA Therapeutics, Acella Pharmaceuticals, Acelrx Pharmaceuticals, Acelyrin, Acenzia, Acepodia, Aceragen, Acer Therapeutics, Acerus, ACE Solutech, Acetylon Pharmaceuticals, Achieve Life Science, Achilles Therapeutics, AC Immune, Aclaris Therapeutics, Acorda Therapeutics, Acoustic MedSystems, Acrivon Therapeutics, Acrotech Biopharma, Actavis (acquired by Watson), Actelion, Acticor Biotech, Actimed Therapeutics, Active Biotech, Active Motif, ActiveSite, ActLight, ActualEyes, Acturum Life, Acucela, Acuitas Therapeutics, Aculys Pharma, Acura Pharmaceuticals, Adagene, AdAlta, Adama, Adamas Pharmaceuticals, Adamis Pharmaceuticals, Adapsyn Bioscience, Adaptimmune, Adaptive Biotechnologies, Adaptive Phage Therapeutics, AdaptVac, ADC Therapeutics, Addex Therapeutics, Adept Neuro, Adhera Therapeutics, Adhesys Medical, Adial Pharmaceuticals, Adicet Bio, Adimab, Aditx Therapeutics, Adlai Nortye, adMare BioInnovations, Admedus, Adnab, Adocia, Adrestia, ADT Pharmaceuticals, Aduro BioTech, Advaccine Biotechnology, Advaite, Advanced Accelerator Applications, Advanced Animal Diagnostics, Advanced BioInformatics, Advanced Biological Laboratories, Advanced Catheter Therapies, Advanced Human Imaging, Advanced Medical Solutions, Advanced Nuclear Medicine Ingredients, Advanced Proteome Therapeutics, Advance Pharmaceutical, Advanz Pharma, Advaxis, Adverum Biotechnologies, Aegerion Pharmaceutical, Aegis Life, Aegis Therapeutics, Aeglea BioTherapeutics, Aelan Cell Technologies, Aelian Biotechnology, Aelis Pharma, Aerami Therapeutics, Aerie Pharmaceuticals, Aerogen, Aeromics, Aerpio Pharmaceuticals, AEterna Zentaris, Aethlon Medical, Aevi Genomic Medicine, Aevitas Therapeutics, AffaMed Therapeutics, Affibody, Affilogic, Affimed Therapeutics, Affinia Therapeutics, Affinivax, AFFiRiS, AffyXell Therapeutics, AFT Pharmaceuticals, AGC Asahi Glass, Agenus Bio, AgeX Therapeutics, Agile Biodetection, Agios Pharmaceuticals, AgMedica Bioscience, AgNovos Healthcare, AgomAb Therapeutics, AgonOx, AgPlenus, AgriCann Solutions, Agroresults, AGTC, Aguettant, AHN Autoimmunity Institute, AiCuris, AIG Hospitals, AIkido Pharma, AIMM Therapeutics, Aimmune Therapeutics, AIT Therapeutics, AiVita Biomedical, Ajinomoto, AJU Pharma, Akaal Pharma, Akari Therapeutics, AkaRx, Akcea Therapeutics, Akebia Therapeutics, Aker BioMarine, Akero Therapeutics, Akers Biosciences, Akili Interactive Labs, Akonni Biosystems, Akouos, Akrevia Therapeutics, Akriveia Therapeutics, AKSO Biopharmaceutical, Alamar Biosciences, Albany Molecular Research, Alba Therapeutics, Albert Einstein College of Medicine, Albireo, Alcon Laboratories, Alcyone Lifesciences, Alder Biopharmaceuticals, Aldevron, Aldeyra Therapeutics, Alector, Aleta Biotherapeutics, Aleva Neurotherapeutics, Alexion Pharmaceuticals, Alex Therapeutics, Alexza Pharmaceuticals, Alfasigma, Algae-C, AlgaEnergy, Algenex, Aligos Therapeutics, AlivaMab Discovery Services, AliveCor, Alive Sciences, Alivio Therapeutics, ALK-Abello, Alkem Laboratories, Alkermes, Allakos, Allarity Therapeutics, AllCells, Allecra Therapeutics, Allegheny General Hospital, Allegheny Technologies, Allele Biotechnology and Pharmaceuticals, Allen Institute for Brain Science, Allergan, Allergan Aesthetics, AllerGenis, Alliance BioEnergy Plus, Alliance Pharma, Allied Corp, Alligator Bioscience, Allist Pharma, Allogene Overland Biopharm, Allogene Therapeutics, Alloksys Life Sciences, AlloVir, AllyAlign Health, Almelo, Almirall, Alnylam Pharmaceuticals, Alopexx, Alpha Biopharma, Alpha Cancer Technologies, Alphageneron Pharmaceuticals, Alphamab Biopharmaceuticals, Alphamab Oncology, Alpine Immune Sciences, Altan Pharma, Alteogen, Alterity Therapeutics, Alternative Solutions, Alternavida, Altesa Biosciences, Alto Neuroscience, Altum Pharmaceuticals, Altus Formulation, Alvit LCS Pharma, Alvogen, Alvotech, Alytas Therapeutics, Alzamend Neuro, AlzeCure Pharma, Alzheon, Alzyn, AM-Pharma, Amagma Therapeutics, Amag Pharmaceuticals, Amarantus BioSciences, Amarin, Amasa Therapeutics, Ambrx, Ambys Medicines, AM Chemicals, Amegabiotech, A Menarini Diagnostics, Amend Surgical, American BriVision, American Cancer Society, American Speech-Language-Hearing Association, American Type Culture Collection (ATCC), Amerigen Pharmaceuticals, Amfora, Amgen, Amneal Pharmaceuticals, Amolyt Pharma, AMO Pharma, Amorsa Therapeutics, AmplyCell, Amplyx Pharmaceuticals, AMR, Amring Pharmaceuticals, Amryt, Amunix, Amyris, Amzell, AN2 Therapeutics, AnaBios, Anagenesis Biotechnologies, Anahit, ANANDA Scientific, Anatara Lifesciences, Anchiano Therapeutics, Andor Pharmaceuticals, Angelini Pharma, AnGes MG, Angiochem, Angion Biomedica, Angionetics, Angios, AngioSoma, Angiostem, AnHeart Therapeutics, Anima Biotech, Animalcare, Animal Life Sciences, ANI Pharmaceuticals, Anivive Lifesciences, Anixa Biosciences, Anji Pharma, Anju Software, Annias Immunotherapeutics, ANP Technologies, Antares Pharma, Antengene, Anteris Bio, Anthos Therapeutics, Antibe Therapeutics, Antibody Solutions, Antigen Express, Antion Biosciences, Antios Therapeutics, Antisoma Therapeutics, AntriaBio, Apceth, APC Therapeutics, Apeiron Biologics, Apellis Pharmaceuticals, Aperion Biologics, Apex Global Brands, Apexian Pharmaceuticals, Apexigen, Aphria, ApiJect Systems, Aplagon, ApolloBio, Apollomics, Apollo Therapeutics, Apotex, Appello Pharmaceuticals, Appia Bio, Appili Therapeutics, Applied Biology, Applied BioSciences, Applied Botanics, Applied DNA Sciences, Applied StemCell, APR Applied Pharma Research, Aprecia Pharmaceuticals, Apricity Health, AprilBio, APRINOIA Therapeutics, Apsen Farmacutica, AptaBio Therapeutics, AptarGroup, Aptarion biotech, Aptar Pharma, Aptevo Therapeutics, Aptinyx, Aptorum Group, Aptose Biosciences, Aquavit Pharmaceuticals, Aquestive Therapeutics, Aquinox Pharmaceuticals, Aquitaine Science Transfert (SATT Aquitaine), Aralez Pharmaceuticals, Aratana Therapeutics, Aravive Biologics, Arbele, Arbor Biotechnologies, Arbormentis, Arbutus, ARCA Biopharma, Arcadia Biosciences, Arcadia Consumer Healthcare, ArcDia, Arcellx, Arch Biopartners, Archer Daniels Midland Company, ArcherDX, Arcis Biotechnology, Arcoral Pharma, ARC Therapeutics, Arctic University of Norway, Arctic Vision, Arcturus Therapeutics, Arcus Biosciences, Arcutis Biotherapeutics, Ardelyx, Arecor, Arena Pharmaceuticals, Ares Genetics, Argentum Pharmaceuticals, argenx, Argon Medical Devices, Ariad Pharmaceuticals, Aridis Pharmaceuticals, Arista Cereal Technologies, Aristea Therapeutics, Arizona State University, Arjuna Naturals, Ark Biosciences, Arno Therapeutics (inactive since 2017), Aro Biotherapeutics, ArQule, Arrakis Therapeutics, Array Biopharma, Arrien Pharmaceuticals, ArriVent Biopharma, Arrowhead Pharmaceuticals, Arrow Pharmaceuticals, Arrys Therapeutics, Arsanis Biosciences, ArsenalBio, ARS Pharmaceuticals, Artelo Biosciences, Artes Biotechnology, Artios Pharma, Artiva Biotherapeutics, Artizan Biosciences, Aruvant Sciences, Arvelle Therapeutics, Arvinas, Asahi Kasei, Ascendance Biotechnology, Ascend Wellness, Ascensia Diabetes Care, Ascentage Pharma, Ascletis, ASC Therapeutics, Asia Green Biotechnology, Asieris MediTech, ASKA Pharmaceuticals, AskAt, AskGene Pharma, Asklepios Biopharmaceutical, Aslan Pharma, Aspargo Laboratories, Aspen Holding, Aspen Pharmacare Canada, Aspire Health Science, Assembly Biosciences, Assistance Publique-Hôpitaux de Paris, Astellas Pharma, Astellas Pharma Europe, Asterias Biotherapeutics, Astex Pharmaceuticals, AstraZeneca, Astrea Bioseparations, Astute Medical, Asuragen, Asylia Therapeutics, Atara Biotherapeutics, Atea Pharmaceuticals, Athena Bioscience, Athenex, Athinoula A Martinos Center for Biomedical Imaging, Atlantic Healthcare, ATMA Journey Centers, Atomwise, Atonco, Atreca, Attillaps Holdings, Attune Medical, ATUM, Atvio Biotech, aTyr Pharma, Auburn University, Aucta Pharmaceuticals, Audax Medical, Audentes Therapeutics, Audio Cardio, Auditus, AUM Biotech, Aura Biosciences, Auransa, AuraVax Therapeutics, Aurealis Therapeutics, Aurigene Discovery Technologies, Aurinia Pharmaceuticals, Aurobindo Pharma, Aurora Cannabis, Aurum Ceramic Dental Laboratories, AusHealth, Australian Biotechnologies, Australian Nuclear Science and Technology Organisation, Australian Research Council, Autifony Therapeutics, Autobahn Therapeutics, Autolus, Automation Anywhere, Autotelic, Autotelic BIO, Auxly Cannabis Group, Avacta, Avactis Biosciences, Avadel Pharmaceuticals, Avalon GloboCare, AvantGen, Avaria Health & Beauty, Avectas, AVEO Oncology, Aveta Biomics, AveXis, Avicanna, Avidea Technologies, Avidity Biosciences, Avion Pharmaceuticals, Avior Bio, Aviragen Therapeutics, AVIR Pharma, Avita Therapeutics, Avitide, Avrobio, Awakn Life Sciences, Axcelead Drug Discovery Partners, AXIM Biotechnologies, Axis Lighting, Axis Therapeutics, AxoSim, Axovant Gene Therapies, Axsome Therapeutics, Axxam, Ayala Pharmaceuticals, Aytu BioPharma, Aziyo Biologics, AzurRx BioPharma, Bach Biosciences, Back-A-Line, Bactevo, Baergic Bio, Baidu, BAKX Therapeutics, Baliopharm, Banyan Biomarkers, Barer Institute, Basilea Pharmaceutica, BAS Research, Batavia Biosciences, BATM, Battelle, Bausch & Lomb, Bausch Health Companies, Bavarian Nordic, Baxalta, Bayer, Bayer Animal Health, Baylor College, Baylor College of Medicine, Baylor Genetics, Baylor Scott and White Research Institute, BayPAT, Bay State Milling Company, Bazelet, BB100, BDD Pharma, Beacon Discovery, Beactica, Beam Therapeutics, Beartooth Therapeutics, Becton Dickinson, BehaVR, BeiGene, Beijing InnoCare Pharma, Beijing SL Pharma, Beijing Strong Biotechnologies, Beijing Tide Pharmaceutical, Beijing University of Chinese Medicine, Belfor, Bellicum Pharmaceuticals, BellRock Brands, Ben-Gurion University, Benaroya Research Institute, Bened Biomedical, BenevolentAI, Benitec Biopharma, Benson Hill Biosystems, Benuvia Therapeutics, Berkeley Lights, Berlin Chemie, Beroni Group, Besins Healthcare, Beth Israel Deaconess Medical Center, Betta Pharmaceuticals, BetterLife Pharma, BevCanna, Beyondspring Pharmaceuticals, BGN Technologies, Bhang, Bharat Biotech, BHVI, Bial, BIA Separations, BICO, Bicycle Therapeutics, Biedermann Motech, Bill and Melinda Gates Foundation, Bintai Kinden, Bio-Gate, Bio-Rad Laboratories, Bio-Techne, Bio-Thera Solutions, Bioadaptives, bioAffinity Technologies, BioAge Labs, BioArctic Neuroscience, BioArdis, biOasis Technologies, BioAtla, BioAxone BioSciences, BioCardia, Biocept, Bioceres, Bioceros, Biocodex, Biocon, BIOCORP, BioCorRx, BioCryst Pharmaceuticals, Biocytogen, BioDelivery Sciences, Bio DG, Biodirection, Bioeq IP, BioGaia, Biogen, BioGenetics, BioGen Medical, Bioharmony Therapeutics, Biohaven Pharmaceutical, BioInvent, Biokit, BioLab Sciences, BioLamina, BioLegend, BiolineRX, BioLite Japan, Biologix FZCo, Biolojic Design, BioMarin Pharmaceutical, Biomed, Biomedical Advanced Research and Development Authority, Biomerica, Biomerics, bioMerieux, Biomm, Biomunex Pharmaceuticals, BiomX, Biond Biologics, BiondVax, Bioneer, Bionomics, BioNova Pharmaceuticals, Bionovus Life Sciences, BioNTech, Bionure, BionX Medical Technologies, Bio Palette, BioPhausia, Bioprojet, BioRAE, BioRap Technologies, BiosanaPharma, Biosceptre International, Biosearch Technologies, BioSense Global, Biosenta, BioSilta, BioSkryb, Biosolution, Biosplice, BioSyent Pharma, Biosynth, BioTheryX, Biotheus, Biotoscana Farma, Biotricity, BioVaxys, Bioventus, Bioverativ, Bird Foundation, Birdie Biopharmaceuticals, Biscayne Neurotherapeutics, Bison & Rose, Bixink Therapeutics, BL&H, Blackford, BlackThorn Therapeutics, Blanver, BlinkBio, BliNK Biomedical, Bliss Biopharmaceutical, Bloom Science, Bluebird Bio, Bluechiip, Blue Earth Diagnostics, BlueJay Therapeutics, Blue Note Therapeutics, Blueprint Medicines, BlueRock Therapeutics, Bluestar Alliance, Blue Water Vaccines, BMV Medica, BNC Korea, BODIMETRICS, Body Labs, Boehringer Ingelheim, Boeing Company, Bolt Biotherapeutics, Bone Biologics, Bone Solutions, Bone Therapeutics, Bophelo Bioscience & Wellness, Boragen, Bora Pharmaceuticals, Boryung Pharmaceutical, Boston Immune Technologies and Therapeutics, Boston Pharmaceuticals, Boston Scientific, Boston Therapeutics, Boston University, BoyaLife, Braeburn Pharmaceuticals, BrainLAB, Breathtec BioMedical, Breath Therapeutics, Breckenridge Pharmaceuticals, BriaCell Therapeutics, Brickell Biotech, BridgeBio Pharma, Bridge Biotherapeutics, Bridge Medicines, BridGene Biosciences, Brigham and Women's Hospital, Bright Future Pharmaceutical Lab, Bright Peak Therapeutics, Brii Biosciences, Brill Pharma, Brink Biologics, Bristol-Myers Squibb, Broad Institute, BroadMed, Brooklyn ImmunoTherapeutics, Brown University, Bruker, Bryn Pharma, BryoLogyx, BTG, Buck Institute for Age Research, Bugworks, Butantan Institute, Byondis, Byrne Medical, C-Bridge Capital, C3i, C4 Therapeutics, C4X Discovery, Cabaletta Bio, Cadent, Cadila Pharmaceuticals, Caelum Biosciences, Caffeluxe, Caladrius Biosciences, Calidi Biotherapeutics, California Institute for Biomedical Research, California Institute of Technology, Calimmune, Calithera Biosciences, Calixar, Calliditas Therapeutics, Calviri, Calypso Biotech, Calyxt, Camarus, Cambrian Biopharma, Cambridge Enterprise, Cambridge Epigenetix, Cambridge Research Biochemicals, CAMP4 Therapeutics, Camurus, Can-Fite BioPharma, Canada House Wellness Group, Canaf Therapeutics, CANbridge Pharmaceuticals, CancerLinQ, Cancer Prevention Pharmaceuticals, Cancer Research Technology, Cancer Research UK, Cancer Targeted Technology, CanCure, Candela, Cannabis OneFive, CannaHoldCo, Cannaponics, CannaRoyalty, CannaSkin, Cannassure Therapeutics, Cannidex Brands, CanniMed Therapeutics, CannPal Animal Therapeutics, Canntab Therapeutics, Canopy Biosciences, Canopy Growth, CanProbe, Cantabria Pharma, Cantargia, Cantex Pharmaceuticals, CAO Pharmaceuticals, Cap Alter Pharma, Capricor Therapeutics, Capsigen, Cara Therapeutics, Caraway Therapeutics, Cardiff University, CardioFocus, Cardiogen Sciences, Cardiome Pharma, CardioSert, Cardiovascular Solutions of Central Mississippi, Cardiowise, Cardurion Pharmaceuticals, CareDx, Caribou Biosciences, Carina Biotech, Carisma Therapeutics, Carmel Pharma, Carmine Therapeutics, Carmot Therapeutics, Carna BioSciences, Carpegen, Carrick Therapeutics, Cascade Pure, Cascadian Therapeutics, Casebia Therapeutics, Case Western Reserve University, CASI Pharmaceuticals, Casma Therapeutics, Cassiopea, Castle Creek Biosciences, Catabasis Pharmaceuticals, Catalent, Catalyst Biosciences, Catalyst Pharmaceutical Partners, Catalyst Pharmaceuticals, Catamaran Bio, Catholic University Leuven, CavoGene LifeSciences, CB2 Therapeutics, CBD Solutions, CBT Pharmaceuticals, Cedilla Therapeutics, Celcuity, Celdara Medical, Celgene, Cella Therapeutics, Cell Cure Neurosciences, Cell Design Labs, Cellecta, Cellectar Biosciences, Cellectis, Cellectricon, Cellenkos, Cellerant Therapeutics, Cellesce, Cellevolve Bio, Cell Guidance Systems, Celling Biosciences, Cellix Bio, Cell Medica, Cell Mogrify, CellProThera, CellSight Technologies, Celltech, Cell Therapy, Cellth Systems, Celltrion, Cellular Biomedicine, Cellular Dynamics International, Cellular Engineering Technologies, Cellumed, Cellvation, Celsee, Celsius Therapeutics, Celularity, Celyad, Cend Therapeutics, Center for Cancer Research, Centessa Pharmaceuticals, Centre for Drug Research and Development (CDRD), Centre for Imaging Technology Commercialization, Centre For The Commercialization Of Antibodies And Biologics, Centrexion, Centro de Investigación Biomédica en Red de Salud Mental, Centurion, Century Therapeutics, Cequr, Cereal Ingredients, Cerecor, Cerevance, Certara, Certis, Cerveau Technologies, CEVA, Ceva Sante Animale, Cevec Pharmaceuticals, CGA 369, CG Oncology, cGreen, Changchun BCHT Biotechnology, Changshan Pharm, Charite Universitatsmedizin Berlin, Charles River Laboratories, Chart Industries, CheckedUp, Checkmate Pharmaceuticals, CheckPoint Immunology, Checkpoint Therapeutics, Chelexa Biosciences, Chemesis, Chemi Pharmaceutical, ChemoCentryx, Chemstar, Chengdu Gaotong Isotope, Cheplapharm Arzneimittel, Chi-Med, Chiesi Farmaceutici, Children's Hospital Boston, Children's Hospital of Philadelphia, Children's Medical Research Institute, Chimeric Therapeutics, Chimerix, China Grand Pharma, China Grand Pharmaceutical, China Medical System, China National Biotech Group (CNBG), China Oncology Focus, China Resources Sanjiu Medical and Pharmaceutical, Chinese University of Hong Kong, Chinook Therapeutics, Chiome Bioscience, Chondrial Therapeutics, Chong Kun Dang, Chongqing Jingdong Pharmaceutical, ChromaDex, Chromocell, Chronix Biomedical, Chugai Pharmaceutical, Chung-Ang University, Cibus Global, Cidara Therapeutics, Cilag AG, CimCure, Cincinnati Children’s Hospital Medical Center, CinCor Pharma, Cinda Bio-Pharmaceutical, Cingulate Therapeutics (CTx), Cipher Pharmaceuticals, Cipla, Circadian Wellness, Circassia, Circulogene, Cirle, Citius Pharmaceuticals, Citranvi Biosciences, Citrine Medicine, Citron Pharma, City of Hope, Civetta Therapeutics, CiVi Biopharma, CJ Corp, Claritas HealthTech, Clarus Therapeutics, ClearLight Biotechnologies, ClearLight Diagnostics, ClearPoint Neuro, Clearside Biomedical, Clearsky Medical Diagnostics, Cleave Therapeutics, Clementia Pharmaceuticals, Cleveland Clinic, Cleveland Diabetes Care, Cleveland Diagnostics, Click Therapeutics, Clinical Laserthermia Systems (CLS), Clinigen, Clover Biopharmaceuticals, Clover Therapeutics, Clovis Oncology, CMS Medical, CN Bio, CNS Pharmaceuticals, Co-Diagnostics, Coalition for Epidemic Preparedness Innovations, Coapt, CoapTech, Coave Therapeutics, Cochlear, Cocoon Biotech, Cocrystal Pharma, Code Biotherapeutics, Codex DNA, Codexis, Codiak BioSciences, Coeptis Pharmaceuticals, Cogentix Medical, Cognoa, CogState, Coherus Biosciences, CoImmune, Cold Spring Harbor, Colgate Palmolive, Collegium Pharmaceuticals, Collplant, Colorcon, Columbia Care, Columbia Technology Ventures, Columbia University, CombiGene, Combioxin, Comercializadora BioRenal, Commense, Complix, Compugen, Conatus Pharmaceuticals, ConcertAI, ConforMIS, Confo Therapeutics, Conkwest, Conmed, Consilient Health, ConsortiaTX, Consulting Group of Jocassee, ConSynance Therapeutics, Contamac, Context Therapeutics, Contextual Genomics, Convelo Therapeutics, ConverGene, Convergent Bioscience, Cook Biotech, Copernicus Therapeutics, Corbin Therapeutics, Corbus Pharmaceuticals, Corden Pharma, Corestem, Corino Therapeutics, CorMedix, Cornell University, Coronado Biosciences, Correvio Pharma, Corsair Pharma, CorTechs Labs, Corteva Agriscience, Corvidia Therapeutics, Corvium, Corvus Pharmaceuticals, Cosette Pharmaceuticals, Cosmo Pharmaceuticals, COUR Pharmaceutical, Covalon Technologies, Covance, COVAXX, Creative Biolabs, Creative Medical Technologies, Crescendo Biologics, Crescita Therapeutics, Cresset, Crinetics, CRISPR Therapeutics, Critical Diagnostics, CROMA Pharma, Crossbeta Biosciences, Crossject, Crown Bioscience, Crown Laboratories, CR Pharma, CRT Pioneer Fund, CrystalGenomics, CSIR-Central Drug Research Institute, CSIRO, CSL, CSL Behring, CSPC Pharmaceutical Group, CStone Pharmaceuticals, CTT Pharmaceutical, CTX Technology, Cue Biopharma, Cullinan Oncology, Cumberland Pharmaceuticals, Cumulus Oncology, Curacle, Curadev Pharma, Curative Biotechnology, CureMetrix, CURE Pharmaceutical, Cures Within Reach, Curetis, CureVac, Curio Wellness, Curis, Curium, Curon Biopharmaceutical, Currax Pharmaceuticals, Cutanea Life Sciences, Cutia Therapeutics, Cutting Edge Healthcare, CvergenX, Cyclenium Pharma, Cycle Pharmaceuticals, Cyclerion Therapeutics, Cyclica, CYduct Diagnostics, Cygnus, CymaBay Therapeutics, Cynata Therapeutics, Cyndea Pharma, Cyntar Ventures, Cyntec, Cyon Therapeutics, Cypralis, Cyprium Therapeutics, Cystic Fibrosis Foundation, Cystron Biotech, Cytocom, Cytodyn, CytoImmune Therapeutics, Cytokinetics, CytomX Therapeutics, Cytos Biotechnology, CytoSen Therapeutics, Cytovance Biologics, Cytovant Sciences, CYTOVIA Therapeutics, CytRx, Cyxone, D. E. Shaw Research, D. Western Therapeutics Institute, D2M, Daewoong Pharmaceutical, Daiichi Sankyo, Daktari Diagnostics, Dalhousie University, Dana-Farber Cancer Institute, Dana Farber Partners Cancer Care, Dare Bioscience, Dartmouth College, DarwinHealth, DAS Therapeutics, DATANet Software Development, Dealmed Medical Supplies, Deargen, Debiopharm, Dechra Pharmaceuticals, Decibel Therapeutics, Deciphera Pharmaceuticals, Deep Genomics, Deerfield Management, DefiniGEN, DEG Productions, Deinove, Delcath Systems, Delivra, DelMar Pharmaceuticals, DelSiTech, Delta 9 Cannabis, DeMelle OncoPharma, Demetrix, Denali Therapeutics, Denka, Denka-KEW Genomics, Denovo Biopharma, Densitas, Densmore Pharmaceutical, Department of Veterans Affairs, DepoMed, DePuy, DermapenWorld, Dermavant Sciences, Dermelix Biotherapeutics, Dermira, Desitin, Desktop Genetics, Destiny Pharma, DeuteRx, Devonian Health Group, Dewpoint Therapeutics, Diaccurate, DiA Imaging Analysis, Dialco Medical, DiaMedica, DIAN Diagnostics, Dianomi Therapeutics, Diaprost, DiCE Molecules, Dicerna Pharmaceuticals, Digestome Therapeutics, Dignity Health, Dimension Therapeutics, DiNAQOR, DiosCURE Therapeutics, Disc Medicine, Distributed Bio, Diurnal, Diverse Biotech, Dixi, DKSH, DNA Script, DNAtrix, DNX Biopharmaceuticals, Dogma Therapeutics, DolCas Biotech, Domain Therapeutics, Dong-A Pharmaceutical, Dong-A ST, DongKoo Bio & Pharma, Door Pharmaceuticals, Dorian Therapeutics, DotBio, Dotmatics, Dow AgroSciences, Dr. Falk Pharma, Dr. Reddy's Laboratories, Dr. U Devices, Draeger Safety Diagnostics, Dragonfly Therapeutics, Dreamy, Dren Bio, Drexel University, Dr Kerklaan Therapeutics, Drug Innovation Ventures at Emory, DS Biopharma, DSM, DSM Sinochem Pharmaceuticals, DuChemBio, Duchesnay, Duke-NUS Graduate Medical School Singapore, Duke University, Dunad Therapeutics, Durect, Dutch SAZ, Dyadic International, Dyamed Biotech, DyDo Pharma, Dynacure, Dynamic Combinatorial Chemistry, Dyna Therapeutics, Dynavax Technologies, Dyno Therapeutics, E-Scape Bio, Eagle Pharmaceuticals, EA Pharma, Eastman Kodak, Easton Pharmaceuticals, Eberhard Karls University Tubingen, Echelon Fitness, ECM Therapeutics, Ecole Polytechnique Federale de Lausanne, Eczacibasi Pharmaceuticals, Eczacıbasi-Monrol, EDAP TMS, Eddingpharm, Edesa Biotech, EdiGene, Edinburgh Innovations, Edison Oncology, Editas Medicine, Educational and Scientific, eFFECTOR Therapeutics, EffRx, Egalet, Egis, Ehave, EhmetDx, Eidos Therapeutics, Eiger BioPharmaceuticals, Eikonoklastes Therapeutics, EirGenix, EirGen Pharma, Eirion Therapeutics, Eisai, Eisai Inc, Elanco, Elasmogen, Elcelyx Therapeutics, Elekta, Elektrofi, Elemaster Group, Elevai Labs, Elevar Therapeutics, Eleven Biotherapeutics, Elexopharm, ELIAS Animal Health, Eligo Bioscience, Eli Lilly, Elis Pharmaceuticals, Elite Pharmaceuticals, Elixirgen, Ellipses Pharma, Elpis Biomed, Elpiscience, ElsaLys Biotech, Eltima Software, Eluminex Biosciences, Elysium Health, Emcure Pharmaceuticals, Emendo Biotherapeutics, Emerald Organic Growth, Emergence Therapeutics, Emergent BioSolutions, Emmaus Life Sciences, Emollivet, Emory University, Empatica, Empirico, Empowered Diagnostics, Enara Bio, Encore Dermatology, Endeavor BioMedicines, Endocanna Health, EndoCeutics, Endocyte, Endo International, EndoLogic, Endo Ventures, Endpoint Health, Engage Therapeutics, EnGeneIC, Engitix, Engrail Therapeutics, Enigma Biomedical, Enleofen Bio, Enochian Biosciences, ENPICOM, Ensemble Therapeutics, Ensoma, Entasis Therapeutics, Entera Health, Enteris Biopharma, Enterome Bioscience, Enterprise Therapeutics, Enthera, Entos Pharmaceuticals, Entrinsic Health Solutions, Enumeral Biomedical, Enveric Biosciences, EnWave, Enzene Biosciences, Enzolytics, Enzymatica, Enzymotec, Enzyvant Science, EOC Pharma, EpicentRx, Epic Sciences, EpiDestiny, Epigen Biosciences, EPI Health, EpimAb Biotherapeutics, Epitomee Medical, Epivax, EpiVax Therapeutics, Epizyme, Epsilogen, Epygen Biotech, eQcell, EQRx, Equilibre BioPharmaceuticals, Equillium, Equinox Science, Er-Kim, Ergomed, ERS Genomics, Ervaxx, ESJ Enterprises, EsoCap, EspeRare Foundation, Esperion Therapeutics, Espero Biopharma, Esteve, ES Therapeutics, EtectRx, eTheRNA immunotherapies, Ethypharm, Eton Pharmaceuticals, Eucodis Bioscience, Eucure Biopharma, Eu Hwa, Eunice Kennedy Shriver Institute of Child Health and Human Development, Eureka Therapeutics, Eurocine Vaccines, Eurofarma, Eurofins Genomics, Eurofins LifeCodexx, Eurofins Scientific, Euroimmun, European Commission, European Equity Partners, EUSA Pharma, Eutilex, Eve & Co, Evecxia, Evelo Biosciences, Everads Therapy, Everest Medicines, EverInsight Therapeutics, Evestra, Evgen Pharma, Evolva, Evommune, Evonik Industries, EVOQ Therapeutics, Evotec, Evox Therapeutics, Evozyne, Ewopharma, Exacis Biotherapeutics, Exact Sciences, Exagen Diagnostics, ExcellaBio, ExCellThera, Excelra, Excision BioTherapeutics, Exelixis, Exeltis, Exicure, Exonics Therapeutics, Exosome Diagnostics, Expansion Therapeutics, Expedeon, Experimental Drug Development Centre, ExpreS2ion Biotechnologies, Expression Therapeutics, ExScientia, Eyam Vaccines and Immunotherapeutics, EyeCRO, Eyegate Pharmaceuticals, Eyenovia, Eyeon Therapeutics, EyePoint Pharmaceuticals, Eyevance, F-Star, F-Star Therapeutics, F1 Oncology, F4 Pharma, Facit, Factor Bioscience, Factorial Diagnostics, Faes Farma, Fagron, FairJourney Biologics, FameWave, Faraday Pharmaceuticals, Fareva Holding, Farmalider, FASMAC, Fate Therapeutics, Fatro, Fauna Bio, Feel Better, Feldan Therapeutics, Felix Biotechnology, Femtogenix, Ferozsons Laboratories, Ferring Pharmaceuticals, FGH Biotech, Fibriant, Fibrocell Science, Fibrocor Therapeutics, Fibrogen, Filament Health, Fin-ceramica faenza spa, Fina Biosolutions, Finch Therapeutics, Fine Foods & Pharmaceuticals N.T.M., First Wave Bio, Fit for Life, FitOn, Five Prime Therapeutics, FKD Therapies, Flame Biosciences, Flexion Therapeutics, Flightpath Biosciences, Florida Pharmaceutical Products, Florida State University, Flow Eighteen38, Flower One, Flow Pharma, Fluicell, Fluidigm, Flynn Pharma, Flywheel, Foamix Pharmaceuticals, Focal Healthcare, Foghorn Therapeutics, Fondazione San Raffaele, Fondazione Telethon, Food and Drug Administration (FDA), Forage Genetics, Forendo Pharma, Foresee Pharmaceuticals, Foresite Capital, Forge Therapeutics, Formac Pharmaceuticals, FORMA Therapeutics, Forte Biotechnology, Fortify Therapeutics, Fortress Biotech, Forty Seven, Forward Pharma, Fosun Pharmaceutical, Foundation for Celiac Disease Outcome Measures, Foundation Medicine, Fox Chase Chemical Diversity Center, Fraunhofer Institute for Molecular Ecology (IME), Frazier Healthcare Ventures, Fred Hutchinson Cancer Research Center, Frequency Therapeutics, Fresenius Kabi Pharmaceuticals, Fresenius Medical Care, Frontier Biotech, Frontier Medicines, Front Range Biosciences, FSD Pharma, Fudan University, Fuhong Hanlin, Fujifilm, FUJIFILM Cellular Dynamics, Fujifilm Kyowa Kirin Biologics, Fuji Pharma, Fujirebio Diagnostics, Fuji Yakuhin, Fulcrum Therapeutics, Fulgent Genetics, Fulgent Pharma, Fundacion Medina, Fusion Pharmaceuticals, FuturaGene, FutureGen Biopharm, G+FLAS Life Sciences, G-Tech Bio, G1 Therapeutics, G3 Pharmaceuticals, Gadeta, Gaelan Medical, Gaeta Therapeutics, Gaia, Galapagos, Galaxy Biotech, Galderma, Galen, Galmed Pharmaceuticals, GamaMabs Pharma, Gan & Lee, GATC Health, GB Sciences, GC Cell, GC LabCell, GC Pharma, Gebro Pharma, Gedeon Richter, GE Healthcare, Gelesis, Gemini Therapeutics, GEMoaB, Gemphire, GEn1E Lifesciences, Genagon Therapeutics, GenAhead Bio, Genco Sciences, GeneBay, Gene Biotherapeutics, GeneData, GenEdit, Genelux, Genentech, Geneos Therapeutics, GeneQuine Biotherapeutics, Generate Biomedicines, Generex Biotechnology, Genesis Therapeutics, Genestack, Genethon, Genetic Analysis, Genetic Immunity, Genetic Information Research Institute, Genetics Research, Genetic Technologies, Genevant Sciences, Genexine, Genexo, Genfit, GenFleet Therapeutics, Genialis, Genisphere, Genmab, Gennova Biopharmaceuticals, Genocea Biosciences, Genome Biologics, Genomic Health, Genomic Vision, Genomma Lab Internacional, Genor Biopharma, Genovis, genOway, Genpharm, Genprex, GenScience Pharmaceuticals, GenScript Biotech, GenScript ProBio, GensKey Medical Technology, GenStem Therapeutics, GentiBio, Genus, GenVec, Genzyme, George Mason University, Georgetown University, George Washington University, Georgia State University Research Foundation (GSURF), Georgia Tech Research Corporation, German Cancer Research Center, Gestion Univalor, Ghent University, Gibson Oncology, Gilead Sciences, Ginkgo BioWorks, Glaukos, GlaxoSmithKline, GlaxoSmithKline Biologicals, GL Brands, Glenmark Pharmaceuticals, Glenmark Pharmaceuticals S.A., Global Antibiotic Research and Development Partnership, Global Blood Therapeutics, Global Cancer Technology, Global Drug Development Centre (GDCC) China, Global Dx, Global Orthopaedic Technology, Global Response Aid, Globavir Biosciences, GlycoBac, GlycoMantra, GlycoMimetics, Glycostem Therapeutics, Glycotope Biotechnology, GlycoT Therapeutics, Glycyx Pharmaceuticals, Glythera, Gnosis Bioresearch, GNS Healthcare, Goethe University Frankfurt, Goldfinch Bio, Goliver Therapeutics, Gossamer Bio, GO Therapeutics, GPCR Therapeutics, Gracell Biotechnologies, Grail, Graviton Bioscience, Gravocore, Greatbatch, Great Belief International, Greenwich LifeSciences, Grenco Science, Grid Therapeutics, Grifols, Gritstone Bio, Grunenthal, Grupo Juste, GS, GT Biopharma, Guangzhou Xiangxue Pharmaceutical, Gubra, Guided Therapeutics, Guohong Guokang (Beijing) Health Technology Development, Gurnet Point Capital, Gynial, Gyroscope Therapeutics, Gyros Protein Technologies, H3 Biomedicine, Hackensack Meridian Health, Hadasit Bioholdings, Hadasit Medical Research Services and Development, Hai Kang Life, Hainan Sinotau Pharmaceutical, Hairmore Group, Haisco Pharmaceutical, Halo Dx, Halo Labs, Halomine, Halozyme Therapeutics, Halt Medical, Halyard Health, Hamad Medical, Hammock Pharmaceuticals, HanAll Pharmaceuticals, HanaVax, Hangzhou Chance Pharmaceuticals, Hangzhou Zhongmei Huadong Pharmaceutical, Hanmi Pharmaceutical, Hansa Biopharma, Hanuman Pelican, HanX Biopharmaceuticals, Hao Le Ku (Beijing) Infant And Maternity, Haplogen, HAPPYneuron, Harbour Biomed, Harmony Biosciences, Harpoon Therapeutics, Harrow Health, Harvard Medical School, Harvard University, Haselmeier, Hatch Medical, HavaH Therapeutics, HCmed Innovations, HCW Biologics, HDT Bio, Healeon Medical, Healis Therapeutics, Health Canada, Healthcare Global Enterprises, Healthe, Healthimation, Health Logic Interactive, HealthLytix, HealthPointe Solutions, Health Sciences Research Institute Germans Trias i Pujol Foundation, Healthy Grain, Healx, HeartHero, Heartseed, Heat Biologics, Hebrew University of Jerusalem, HEC Pharm, Heidelberg Pharma, HekaBio, Helen F Graham Cancer Center, Helio Health, Helix BioPharma, Helmholtz Zentrum Munchen, Helsinn Healthcare, Helsinn Therapeutics, Hemera Biosciences, HemoCleanse, Hemogenyx, HemoShear, Hemostemix, Henlius Biotech, Hennig, Henry Ford Health System, Henry M. Jackson Foundation, Herbolea Biotech, Heritage Cannabis, Hesperos, Hetero Labs, Heumann Pharma Generics, HiFiBio, Highland Pharmaceutical, HighLife, High Line Bio, Hikma Pharmaceuticals, Hill Dermaceuticals, HilleVax, Histogen, Histogenics, Hisun BioRay, HitGen, HLS Therapeutics, Hoffmann La Roche, HoliStick Medical, Hologic, HoMedics, Homology Medicines, Honor, Hookipa Pharma, HOPE BIOSCIENCES, Hope Medicine, Hopstem Biotechnology, Horama

 

For a full list of companies please contact us on enquiry@currentpartnering.com

Current Partnering reports provide insight into the trends and terms of partnering deals in the global life sciences sector.

Current Partnering reports are updated every six months to ensure the user has access to the latest announcements and trends in the topic focus of the report.

Current Partnering analysts review the deal data to provide an overview and analysis of deal trends, including example deals and terms.

Current Partnering reports source deal data from our proprietary deals and alliances database, Current Agreements. The database is updated daily by our analysts with new deals as they are announced globally by the company’s party to the deal. In addition, deal records are updated with new data as it becomes available.

The data in the Current Agreements deals and alliances database is obtained from secondary sources such as publicly available industry sources including press releases, company presentations, investor presentations, company SEC filings, other company filings, company websites, conference presentations. Sources are identified to allow for user verification.

Current Partnering provides comprehensive coverage of the following partnering or deal types:
• Asset purchase
• Assignment
• Co-development
• Co-market
• Co-promotion
• Collaborative R&D
• Contract service
• CRADA
• Cross-licensing
• Development
• Distribution
• Equity purchase
• Evaluation
• Grant
• Joint venture
• Licensing
• Loan
• Manufacturing
• Marketing
• Option
• Promotion
• Research
• Royalty financing
• Settlement
• Spin out
• Sub license
• Supply
• Termination
• Warrant

Every deal record is fully categorized and includes the following data, where available:
• Industry sector
• Therapy areas
• Technology type
• Deal components
• Financial terms
• Stage of development
• Exclusivity
• Asset type
• Geographic focus
• Excluded geography
• Company press release
• SEC filing data including contract document

All financial amounts are converted to US$ using the exchange rate available on the date of deal announcement, enabling direct comparison of deal terms across international territories.

Financial data and contract documents displayed in deal records is obtained from public sources, where disclosed by the parties to the deal.

We found other products you might like!